MAPT and Alzheimer disease: Similarly, whereas higher serum triglyceride levels in older adults may reduce AD risk and slow cognitive decline, higher levels in midlife are associated with abnormal Aβ and tau levels two decades later (28, 33, 34), although these risks may be modified by APOE genotype (35).